The results of an additional secondary endpoint from the phase 3 HERO study evaluating oral relugolix in men with advanced prostate cancer showed that relugolix had a similar rate of castration resistance-free survival compared to intravenous leuprolide acetate in men with metastatic disease through 48 weeks.
Read More
Study: Having Pets Linked to Better Mental Health, Reduced Loneliness During COVID-19 Lockdown
September 29th 2020Survey shows that having a pet was linked to maintaining better mental health and reduced loneliness, with 90% of the 6000 participants from the UK saying they had at least 1 pet.
Read More
Monday Pharmaceutical Mystery: What Caused Health-conscious People to Get Incredibly Sick in 1989?
September 28th 2020In 1989, more than 1500 young, healthy people started experiencing mysterious symptoms that included unusual skin rashes, muscle pains, dramatic eosinophilia, and tightening of the skin.
Read More
Study Shows Tethering Together Type 2 Diabetes Drugs Increases Efficacy of Combination Therapy
September 25th 2020Researchers at Duke University have found that the efficacy of a 2-pronged type 2 diabetes (T2D) treatment increases when the drugs are linked by a heat-sensitive tether rather than simply being concurrently administered, according to a press release.
Read More